AUTHORS

Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
Email Bruce Kamich

Recent Articles By The Author

Coupang Could Make a Bigger Trading Bounce

Bruce Kamich

Here's where nimble traders could probe the long side.

Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?

Bruce Kamich

Let's check the charts on this biotechnology stock and see if it still has a prayer.

Shares of Xencor Could Be Bought on a 50% Correction

Bruce Kamich

Traders should remain patient.

Nuvalent Has Begun the Bottoming Process

Bruce Kamich

Let's check the charts and indicators.

Enanta Pharmaceuticals Bounces Off a Key Support Level Once Again

Bruce Kamich

The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.

CRISPR Therapeutics Has Turned the Corner

Bruce Kamich

Here's our current price target.

Little-Known Akoya Biosciences Appears to Have Found a Bottom

Bruce Kamich

The stock of the life sciences company has found buying interest at a key support level.

For This REIT It's All About That Base

Bruce Kamich

We're checking the charts and indicators on Ventas, owner of senior housing and medical facilities.

National Health Investors Is Aging Well as It Emerges From a Base Formation

Bruce Kamich

Buyers of the shares are becoming more aggressive.

General Mills Is Seeing New Highs on the Charts

Bruce Kamich

Here's what traders looking to go long GIS could do.

Load More

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight